ClinicalTrials.gov record
Completed Phase 2 Interventional

Pilot Study For Hypothermia Treatment In Hyperammonemic Encephalopathy In Neonates And Very Young Infants

ClinicalTrials.gov ID: NCT01624311

Public ClinicalTrials.gov record NCT01624311. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Hypothermia Treatment in Hyperammonemia and Encephalopathy

Study identification

NCT ID
NCT01624311
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Uta Lichter-Konecki
Other
Enrollment
5 participants

Conditions and interventions

Interventions

  • Standard of Care Therapy Other
  • Therapeutic Hypothermia Other

Other

Eligibility (public fields only)

Age range
1 Day to 30 Days
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2007
Primary completion
Apr 30, 2015
Completion
Apr 30, 2015
Last update posted
May 31, 2015

2007 – 2015

United States locations

U.S. sites
3
U.S. states
3
U.S. cities
3
Facility City State ZIP Site status
Children's National Medical Center Washington D.C. District of Columbia 20010
Columbia University, Morgan Stanley Children's Hospital New York New York 10027
Medical College Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01624311, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 31, 2015 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01624311 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →